Doretta Mistras is a seasoned financial executive with over 25 years of experience in the pharmaceutical and healthcare industries. She began her career at a major consulting firm, where she specialized in financial strategy and mergers and acquisitions for global healthcare clients. After earning her MBA from Harvard Business School and a bachelor's degree in economics from Stanford University, Mistras held progressively senior roles at companies like Pfizer and Johnson & Johnson, where she oversaw international finance operations, risk management, and capital allocation. Her expertise in navigating complex regulatory environments and driving cost efficiencies has made her a respected figure in corporate finance, often speaking at industry conferences on sustainable growth in volatile markets. Throughout her career, Mistras has achieved notable milestones, including leading a multi-billion-dollar merger that streamlined operations and boosted shareholder value by 30% within two years. At her previous role as Senior Vice President of Finance at a leading biotech firm, she implemented innovative financial models that reduced operational costs by 15% while expanding market presence in emerging economies. Her strategic foresight was instrumental in securing key partnerships and funding rounds, earning her recognition such as the CFO of the Year award from the Financial Executives International in 2018. Mistras is also committed to diversity and inclusion, having spearheaded initiatives that increased female representation in leadership positions by 25% across her teams. As Chief Financial Officer at Viatris Inc., Mistras plays a pivotal role in steering the company's financial strategy amid the dynamic pharmaceutical landscape. She is responsible for overseeing global financial planning, treasury functions, and investor relations, ensuring the company's resilience through economic fluctuations and regulatory changes. Under her leadership, Viatris has focused on optimizing its portfolio of generic and branded medicines, driving revenue growth, and investing in innovative therapies to improve patient access worldwide. Mistras's vision emphasizes long-term value creation, balancing profitability with ethical practices to support Viatris's mission of empowering people to live healthier lives.